| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $-0.175 (Miss by $-0.075) |
| EPS GAAP Actual | $-0.175 (Miss by $-0.075) |
| Revenue Actual | $0.223652B |
| Revenue Surprise | Beat by $223.652M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.1678 |
| EPS GAAP Estimate | $0.1678 |
| Revenue Estimate | $0.2398045B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2029 | 25.7343 | 0.39 | 21.45621 | 34.03816 | 1 |
| Sep 2028 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0046 | -0.0046 | 0.223652B | 60.08% | 223.65M |
| FQ2 2025 (Jun 2025) | 0.9 | 0.9 | 0.198644B | 47.59% | 198.64M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 0.181712B | 38.47% | 181.71M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.162306B | 54.54% | 162.31M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.089275B | 42.02% | 89.28M |
| FQ2 2024 (Jun 2024) | -1.03 | -1.03 | 0.104108B | 56.41% | 104.11M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.111799B | 62% | 111.8M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0.073786B | 62.3% | 73.79M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.1678
Consensus Revenue Estimates
0.2398045B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0 | -- | 0 | 0 | 1 |
| FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 1 |
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 1 |
| FQ2 2027 (Jun 2027) | 0.13359 | -- | 0.12051 | 0.15668 | 1 |
| FQ1 2027 (Mar 2027) | 0.13566 | -- | 0.12238 | 0.15911 | 1 |
| FQ4 2026 (Oct 2026) | 0.1861 | -- | 0.10312 | 0.28425 | 0 |
| FQ3 2026 (Jul 2026) | 0.1784 | 102.58 | 0.09885247 | 0.27249 | 0 |
| FQ2 2026 (Jun 2026) | 0.1784 | -404.48 | 0.14494 | 0.22768 | 0 |
| FQ1 2026 (Mar 2026) | 0.1678 | -- | 0.13633 | 0.21415 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0.41B | -- | 0.32B | 0.51B | 1 |
| FQ1 2028 (Mar 2028) | 0.46B | -- | 0.36B | 0.56B | 1 |
| FQ4 2027 (Dec 2027) | 0.39B | -- | 0.3B | 0.47B | 2 |
| FQ2 2027 (Jun 2027) | 0.18B | -- | 0.16B | 0.2B | 1 |
| FQ1 2027 (Mar 2027) | 0.18B | -- | 0.17B | 0.2B | 1 |
| FQ4 2026 (Oct 2026) | 0.5B | -- | 0.33B | 0.7B | 1 |
| FQ3 2026 (Jul 2026) | 0.43B | 48.01 | 0.28B | 0.6B | 1 |
| FQ2 2026 (Jun 2026) | 0.26B | 23.08 | 0.22B | 0.31B | 1 |
| FQ1 2026 (Mar 2026) | 0.24B | 24.22 | 0.21B | 0.29B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
2
EPS # of in-lines
5
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0046 | -0.0046 | 100% | |
| FQ2 2025 (Jun 2025) | 0.9 | 0.9 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | -1.03 | -1.03 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.22B | $223.65M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.2B | $198.64M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.18B | $181.71M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.16B | $162.31M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.09B | $89.28M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.1B | $104.11M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.11B | $111.8M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.07B | $73.79M | 100% |